Why SIRS Criteria Were Replaced
The IPSCC criteria used SIRS-based definitions that had poor predictive properties for identifying children at risk of death or serious morbidity. SIRS criteria captured many febrile children with benign viral illnesses while potentially missing children with "quiet" sepsis who had poor perfusion without meeting inflammatory criteria. The Phoenix criteria address this limitation by focusing on objective organ dysfunction rather than inflammation alone.
The Phoenix Sepsis Criteria
The Society of Critical Care Medicine recommends that sepsis in children be identified by a Phoenix Sepsis Score of at least 2 points in children with suspected infection, which indicates potentially life-threatening dysfunction of the respiratory, cardiovascular, coagulation, and/or neurological systems. Children with a Phoenix Sepsis Score ≥2 had in-hospital mortality of 7.1% in higher-resource settings and 28.5% in lower-resource settings, more than 8 times that of children with suspected infection not meeting these criteria.
Septic shock is defined as children with sepsis who have cardiovascular dysfunction, indicated by at least 1 cardiovascular point in the Phoenix Sepsis Score, which includes severe hypotension for age, blood lactate exceeding 5 mmol/L, or need for vasoactive medication. Children with septic shock had in-hospital mortality rates of 10.8% and 33.5% in higher- and lower-resource settings, respectively.
Use the Phoenix Sepsis Score calculator to score organ dysfunction at the bedside.
Phoenix Sepsis Score Components
The Phoenix Sepsis Score evaluates four organ systems with the following point allocations:
Respiratory dysfunction (0-3 points): Based on PaO2/FiO2 ratio (or SpO2/FiO2 ratio) and respiratory support requirements. Invasive mechanical ventilation and impaired gas exchange contribute points.
Cardiovascular dysfunction (0-6 points): Assessed by age-adjusted severe hypotension, blood lactate >5 mmol/L, or need for vasoactive medications. This is the highest-weighted domain, reflecting the critical importance of hemodynamic instability.
Coagulation dysfunction (0-2 points): Based on platelet count, INR, fibrinogen, and D-dimer. Coagulopathy reflects consumptive processes and endothelial dysfunction.
Neurologic dysfunction (0-2 points): Assessed by Glasgow Coma Scale and pupillary reaction. Altered mental status indicates central nervous system compromise.
The organ-specific subscores sum to the total Phoenix Sepsis Score (maximum 13 points). Higher scores indicate worse organ dysfunction and worse prognosis. Notably, renal and hepatic dysfunction are not scored components of the core Phoenix criteria, though an expanded Phoenix-8 Score including these systems is available for research purposes.
Performance of Phoenix Criteria
The Phoenix criteria demonstrated superior performance compared to IPSCC criteria across diverse settings:
- Higher positive predictive value: Phoenix sepsis criteria had PPV of 5.3-7.1% (baseline mortality 0.6-0.7%) compared to IPSCC severe sepsis criteria PPV of 3.6-4.8%
- Higher or comparable sensitivity: Phoenix criteria sensitivity of 69.2-84.4% compared to IPSCC sensitivity of 58.7-70.7%
- Validated across resource settings: Derived from >3 million encounters across 10 sites in the US, Colombia, Bangladesh, China, and Kenya
A 2026 multicenter European validation study confirmed that Phoenix criteria showed higher predictive performance than IPSCC criteria, with sensitivity of 96.4% and PPV of 7.6% on day 1 of PICU admission.
Important distinction: the Phoenix criteria are intended for diagnosis, benchmarking, quality improvement, and research. They are not designed as screening tools or to guide treatment decisions. Separate early recognition tools for screening are under development.
Pediatric Sequential Organ Failure Assessment (pSOFA)
The pSOFA score adapts the adult SOFA score for pediatric use, evaluating six organ systems: respiratory (PaO2/FiO2), coagulation (platelets), hepatic (bilirubin), cardiovascular (mean arterial pressure and vasopressor requirements), neurologic (GCS), and renal (creatinine). Each domain is scored 0-4, yielding a total score of 0-24.
The Phoenix Sepsis Score was derived in part from pSOFA subscores, with some levels collapsed when performance was unaffected (e.g., pSOFA respiratory subscores of 1 and 2 points were collapsed into a single level). The Phoenix Score prioritizes simplicity and lower dependence on laboratory measures while maintaining predictive performance.
Use the pSOFA Score for serial assessment at the bedside.
Vasoactive-Inotropic Score (VIS)
The VIS quantifies the degree of cardiovascular support required:
VIS = dopamine (mcg/kg/min) + dobutamine (mcg/kg/min) + [100 × epinephrine (mcg/kg/min)] + [100 × norepinephrine (mcg/kg/min)] + [10 × milrinone (mcg/kg/min)] + [10,000 × vasopressin (U/kg/min)]
Higher VIS indicates greater medication burden and more severe circulatory instability. VIS has been validated in pediatric sepsis, with VIS at 48 hours showing the strongest correlation with ICU length of stay (r=0.53) and ventilator days (r=0.52). For every unit increase in VIS at 48 hours, there was a 13% increase in ICU length of stay and 8% increase in ventilator days.
Use the VIS Score to track vasopressor requirements.
VIS Trajectory Groups
A 2022 study identified four distinct VIS trajectory patterns in critically ill children with shock:
- Mild, fast resolving shock (47%): 9% mortality
- Moderate, slow resolving shock (23%): 15% mortality
- Moderate, prolonged shock (17%): 21% mortality
- Severe, prolonged shock (13%): 40% mortality
The "mild, fast resolving" and "severe, prolonged" groups were identifiable within the first 24 hours, while the two moderate groups were indistinguishable early but diverged in outcomes. Trending VIS provides critical clinical information: rising VIS indicates clinical deterioration despite treatment, while falling VIS suggests therapeutic response.
Pediatric Early Warning Scores (PEWS)
PEWS systems are designed to identify deteriorating children before they develop sepsis or require ICU transfer. The Bedside Paediatric Early Warning System (BedsidePEWS) is a validated 7-item score (range 0-26) that quantifies severity of illness in hospitalized children.
In a multicenter randomized trial (EPOCH), BedsidePEWS implementation was evaluated across 21 hospitals. PEWS scores increase over the 24 hours preceding urgent PICU admission, providing early warning of deterioration. At a score of 8, sensitivity was 82% and specificity was 93% for identifying children requiring urgent ICU admission.
A 2026 comparative study found that the Parshuram (BedsidePEWS) model demonstrated the highest diagnostic accuracy among four PEWS models evaluated, with AUC of 0.816 for ICU admissions at a threshold score ≥8.
Use the PEWS Calculator for bedside scoring.
Fluid Resuscitation: Current Evidence
The 2025 AHA/AAP Pediatric Advanced Life Support guidelines provide updated recommendations for fluid resuscitation in pediatric septic shock:
- Reassess after every fluid bolus to assess for fluid responsiveness and signs of volume overload (Class 1 recommendation)
- Either 10 mL/kg or 20 mL/kg aliquots are reasonable as initial fluid bolus volume with frequent reassessment (Class 2a)
- Either isotonic crystalloids or colloids can be effective as initial fluid choice (Class 2a)
- Either balanced or unbalanced solutions can be effective, though balanced crystalloids are generally preferred (Class 2a)
- Epinephrine or norepinephrine as initial vasoactive infusion for fluid-refractory septic shock (Class 2a)
Evidence now supports judicious fluid resuscitation with frequent reassessment rather than aggressive volume loading. Two randomized trials showed that patients receiving higher fluid volumes or faster fluid resuscitation were more likely to develop clinically significant fluid overload with increased rates of mechanical ventilation and worsening oxygenation.
Lactate-Guided Resuscitation
Blood lactate provides a valuable indirect marker of tissue hypoperfusion. Key thresholds:
- Lactate >2 mmol/L: Associated with mortality of 32.0% vs. 16.1% if ≤2 mmol/L in children with hypotension requiring vasopressors
- Lactate >4 mmol/L: Consistently associated with mortality across studies
- Lactate >5 mmol/L: Contributes to cardiovascular points in Phoenix Sepsis Score
Normalization of lactate within 2-4 hours of presentation is associated with decreased risk of persistent organ dysfunction (adjusted RR 0.47). The Surviving Sepsis Campaign suggests using trends in blood lactate levels, in addition to clinical assessment, to guide resuscitation.
Vasoactive Medications
For fluid-refractory septic shock, current guidelines recommend:
- Epinephrine or norepinephrine as first-line vasoactive agents
- Two pediatric RCTs demonstrated improvement in timing of shock resolution and 28-day mortality with epinephrine over dopamine
- Dopamine may be considered if epinephrine or norepinephrine are unavailable
- Stress-dose corticosteroids may be reasonable for septic shock unresponsive to fluids and requiring vasoactive support, though evidence is mixed
Red Flags Requiring Urgent Evaluation
Fever alone is not sufficient for sepsis diagnosis. However, the following combinations warrant urgent evaluation:
- Fever with disproportionate tachycardia
- Petechial rash (concerning for meningococcemia)
- Altered mental status
- Elevated lactate (>2 mmol/L)
- Prolonged capillary refill (>3 seconds) with weak pulses
Initial Management Bundle
When sepsis is suspected:
- Blood cultures before antibiotics, but do not delay treatment
- Antibiotics within 60 minutes, broadest spectrum appropriate for age and suspected source
- IV fluids: 10-20 mL/kg isotonic crystalloid boluses, reassessing after each bolus; up to 40-60 mL/kg total in the first hour if needed, discontinued if signs of fluid overload develop
- Lactate measurement: Repeat if initial value >2 mmol/L
- Vasopressors (epinephrine or norepinephrine) if hypotension persists after adequate fluid resuscitation
- Calculate Phoenix Sepsis Score at admission and serially every 4-6 hours
Serial Scoring and Monitoring
Reassess Phoenix Sepsis Score and/or pSOFA every 4-6 hours. Improving scores indicate effective treatment; stagnant or worsening scores necessitate treatment intensification and reassessment of diagnosis.
Lactate clearance is a real-time marker of perfusion adequacy. A decline >10-15% per hour represents appropriate response. Stagnant or rising lactate despite aggressive resuscitation suggests inadequate source control, resistant infection, or insufficient resuscitation.
VIS trending provides additional prognostic information. Rising VIS indicates clinical deterioration; falling VIS suggests therapeutic response. If vasopressor requirements escalate and VIS remains elevated after 4-6 hours of aggressive management, consider occult source of infection, inadequate source control, or resistant organisms.
Key Clinical Priorities
- Use Phoenix criteria for sepsis diagnosis: Phoenix Sepsis Score ≥2 in children with suspected infection
- Identify septic shock: Sepsis plus ≥1 cardiovascular point (severe hypotension, lactate >5 mmol/L, or vasoactive requirement)
- Administer fluids judiciously: 10-20 mL/kg boluses with reassessment after each; discontinue if signs of fluid overload
- Start vasopressors early for fluid-refractory shock (epinephrine or norepinephrine preferred)
- Monitor lactate trends: Target normalization within 2-4 hours
- Score serially: Phoenix/pSOFA every 4-6 hours to track response
- Remember age-specific thresholds: Phoenix and pSOFA calculators are age-adjusted
The sepsis bundle components, early recognition, antibiotics, fluid resuscitation, vasopressor support, and source control, are interdependent and time-critical. Phoenix and pSOFA scores function as a clinical dashboard, monitoring whether interventions are achieving the desired physiologic response.
References
- Sanchez-Pinto LN, Bennett TD, DeWitt PE, et al. Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024;331(8):675-686.
- Schlapbach LJ, Watson RS, Sorce LR, et al. International Consensus Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024;331(8):665-674.
- Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020;21(2):e52-e106.
- Marchetto L, Daverio M, Comoretto R, et al. Predictive and Prognostic Performance of the Phoenix Sepsis Criteria and Phoenix Sepsis Score in PICU Patients With Suspected Infection: A Multicenter Prospective Study. Crit Care Med. 2026.
- Watson RS, Carrol ED, Carter MJ, et al. The Burden and Contemporary Epidemiology of Sepsis in Children. Lancet Child Adolesc Health. 2024;8(9):670-681.
- McIntosh AM, Tong S, Deakyne SJ, Davidson JA, Scott HF. Validation of the Vasoactive-Inotropic Score in Pediatric Sepsis. Pediatr Crit Care Med. 2017;18(8):750-757.
- Belletti A, Lerose CC, Zangrillo A, Landoni G. Vasoactive-Inotropic Score: Evolution, Clinical Utility, and Pitfalls. J Cardiothorac Vasc Anesth. 2021;35(10):3067-3077.
- Perizes EN, Chong G, Sanchez-Pinto LN. Derivation and Validation of Vasoactive Inotrope Score Trajectory Groups in Critically Ill Children With Shock. Pediatr Crit Care Med. 2022;23(12):1017-1026.
- Parshuram CS, Hutchison J, Middaugh K. Development and Initial Validation of the Bedside Paediatric Early Warning System Score. Crit Care. 2009;13(4):R135.
- Parshuram CS, Dryden-Palmer K, Farrell C, et al. Effect of a Pediatric Early Warning System on All-Cause Mortality in Hospitalized Pediatric Patients: The EPOCH Randomized Clinical Trial. JAMA. 2018;319(10):1002-1012.
- Tazegul M, Turkmen Karaagac A, Guven S. Comparative Evaluation of Different Pediatric Early Warning Scores in Predicting Clinical Outcomes in Pediatric Emergency Observation Units. Pediatr Emerg Care. 2026;42(3):e52-e59.
- Lasa JJ, Dhillon GS, Duff JP, et al. Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Pediatrics. 2026;157(1):e2025074351.